Register
Login:
Share:
Email Facebook Twitter


ETF Investing made simple; CEO of justETF explains why


Verona Pharma Share Price (VRP)



Share Price Information for Verona Pharma (VRP)


Share Price: 126.50Bid: 123.00Ask: 130.00Change: 0.00 (0.00%)No Movement on Verona Pharma
Spread: 7.00Spread as %: 5.69%Open: 126.50High: 126.50Low: 126.50Yesterday’s Close: 126.50

Verona Pharma Plc Ord 5P

Verona Pharma is listed in the FTSE AIM All-Share
Verona Pharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
126.50

Share Price SpacerBid
123.00

Share Price SpacerAsk
130.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
22,695

Share Price SpacerOpen
126.50

Share Price SpacerHigh
126.50

Share Price SpacerLow
126.50

Share Price SpacerClose
126.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 51.36m £64.97m 1,000

52 Week High 150.00 52 Week High Date 13-FEB-2017
52 Week Low 2.80 52 Week Low Date 10-JUN-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
6 7,295 400 -3.466 -36.50 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

23-Feb-17
11:31:00
125.21
225
Sell* 
123.00
130.00
281.72
Trade Type:
Ordinary

23-Feb-17
09:44:06
126.50
15,000
 
123.00
130.00
18.98k
Trade Type:
Ordinary

23-Feb-17
09:35:57
125.21
5,000
Sell* 
123.00
130.00
6,261
Trade Type:
Ordinary




View more Verona Pharma trades >>

Directors Deals for Verona Pharma (VRP)
Trade DateActionNotifierPriceCurrencyAmountHolding
09-Aug-16Buy
Trade Notifier Information for Verona Pharma
Sven Jan-Anders Karlsson held the position of CEO at Verona Pharma at the time of this trade.
 Sven Jan-Anders Karlsson
3.25GBX600,0003470000
20-Jan-16Buy
Trade Notifier Information for Verona Pharma
David Ebsworth held the position of Non-Executive Chairman at Verona Pharma at the time of this trade.
 David Ebsworth
2.5GBX400,0004599774
03-Dec-15Buy
Trade Notifier Information for Verona Pharma
David Ebsworth held the position of Non-Executive Chairman at Verona Pharma at the time of this trade.
 David Ebsworth
3.25GBX370,0004199774
View more Verona Pharma directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Wed 21:32wudiThe company's ticker will be PIRO126.50No Opinion
Private Investor Revenge Organisation. Track down all those fat cats, the revenue will be huge.
Wed 20:47ThelixRE: Thelix, not quite right126.50No Opinion
Too true Wudi...Too true.

Who wants to join me making a company and AIM listing it with lots of good intention RNS's and placing it all the time?

I assume its legal - Most AIM companies do exactly that.
Wed 16:38wudiThelix, not quite right126.50No Opinion
AIM market produces multi-millionaire CEOs.
Wed 16:30ThelixRE: buddyhell126.50No Opinion
Welcome to AIM - 99.999% of all companies ever listed produced absolutely nothing.
Wed 14:12disappointedbuddyhell126.50No Opinion
A good, robust evaluation of the company's performance, going back many years.
I find it difficult to think of a better niche where one could take a nice little earner for achieving bugger all, just stoking it up, occasionally with the same old predictions of future success, which are never achieved.
I try to achieve professional standards in my business dealings, and would expect to be roundly castigated, or more likely, sued, if I took clients money, did bugger all, and fobbed them off… Read More
Wed 12:29ThelixRE: confused with rns126.50No Opinion
rhodi - when performing trials on ill people you cannot just take them off medication that definitely works - it is unethical.

Add on trials are very normal these days and nothing to be concerned about.

As to its side effect profile - most drugs have side effects so again not too worried.

GWP did the same thing - their trials used combination of what the patients were already taking with the new compound.

rpl554 has been proved to phase 1/2 level - it is unethical to use it as a… Read More

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Verona Pharma (VRP) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.